𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti–obesity and anti–diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance

✍ Scribed by Nakagawa, T; Ogawa, Y; Ebihara, K; Yamanaka, M; Tsuchida, A; Taiji, M; Noguchi, H; Nakao, K

Book ID
110045142
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
208 KB
Volume
27
Category
Article
ISSN
1476-5497

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of escitalopram on the regulatio
Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress
✍ Olaf Schulte-Herbrüggen; Eberhard Fuchs; Nashat Abumaria; Annerose Ziegler; Heid 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

## Abstract Escitalopram (ES‐CIT) is a widely used, highly specific antidepressant. Until now there has been very little evidence on how this drug under pathological conditions affects an important feature within the pathophysiology of stress‐related disorders such as depression: the endogenous neu

Comparison of the anti-diabetic effects
Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1–39)amide
✍ Nigel Irwin; Paula L. McClean; Roslyn S. Cassidy; Finbarr P. M. O'Harte; Brian D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract ## Background The two major incretin hormones, glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) are being actively explored as anti‐diabetic agents because they lower blood glucose through multiple mechanisms. The rapid inactivation of GIP and GLP‐